Contract Services Providers play a key role in the success of a drug development and manufacturing program. Hence the need to develop the right sourcing methodologies for Biotech and Pharma companies.
From Drug Discovery & Hit Generation to Clinical & Commercial Supply, efficient sourcing processes enable sponsors to select optimal economical, technological and value-creating solutions across the entire value chain.
Leveraging Lensource®, our proprietary sourcing solution, we enhance our clients' search for contract services partners. So they can advance their programs smoothly, fast and cost-effectively.
Lensource® is a proprietary process that combines our people's biopharma outsourcing expertise with advanced AI technologies—to provide sponsors with actionable insights at a faster pace and deeper level.
100+ CRO, CDMO, CMO and CTS sourcing projects handled for Biotech and Pharma companies each year
2000+ Contract Service Providers (CSP) monitored daily via Lensource®
500Mn industry data collected, processed and analysed each year
Full Coverage of drug R&D and manufacturing value chain, CSP typologies and drug modalities
Divided into 3 independent phases, Lensource® is designed to integrate each client's unique requirements and provide them with an optimal, fact-based, decision-making dashboard.
360° screening & identification based on client's specific search criteria, offering a complete view of all the potential Contract Services partners available.
Deep technical capabilities assessment and CDA process management—leading to the generation of our Lensource® RFI matrix, developed for optimal technical data collection, standardization and comparability.
Proposals and Quotations gathering and analysis—leading to the generation of our Lensource® RFQ matrix, developed for optimal pricing collection, standardization and comparability.
Whether they are innovative start-up Biotech or top 10 Big Pharma companies, Lensource® solves most sourcing challenges our clients are facing. Ultimately allowing them create value all along their drug development or manufacturing programs